AROA BIOSURGERY LIMITED — Share Issue/Capital Change 2023

Jan 11, 2023

Notification of cessation of +securities

==> picture [21 x 22] intentionally omitted <==

Announcement Summary

Entity name

AROA BIOSURGERY LIMITED

Announcement Type

New announcement

Date of this announcement

Thursday January 12, 2023

Details of +securities that have ceased

		Number of
ASX +security		+securities that	The +securities have	Date of
code	Security description	have ceased	ceased due to	cessation
ARXAF	OPTION EXPIRING	203	Cancellation by agreement	04/01/2023
	13-NOV-2027 EX $0.87		between the entity and the
			holder

Refer to next page for full details of the announcement

Notification of cessation of +securities

1 / 4

Notification of cessation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 1 - Announcement Details

1.1 Name of +Entity

AROA BIOSURGERY LIMITED

We (the entity named above) provide the following information about our issued capital.

1.2 Registered Number Type

ARBN

Registration Number 638867473

1.3 ASX issuer code

ARX

1.4 The announcement is

==> picture [8 x 8] intentionally omitted <==

New announcement

1.5 Date of this announcement

12/1/2023

Notification of cessation of +securities

2 / 4

Notification of cessation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 2 - Details of +equity securities or +debt securities that have ceased

ASX +Security Code and Description

ARXAF : OPTION EXPIRING 13-NOV-2027 EX $0.87

Unquoted +equity securities that have ceased

Number of securities that have ceased

203

Reason for cessation

Cancellation by agreement between the entity and the holder

Date of cessation Is the entity paying any consideration for the cessation? No 4/1/2023

Any other information the entity wishes to notify to ASX about the cessation?

None.

Notification of cessation of +securities

3 / 4

Notification of cessation of +securities

==> picture [21 x 22] intentionally omitted <==

Part 3 - Issued capital following changes

Following the cessation of the +securities the subject of this notification, the issued capital of the entity will	Following the cessation of the +securities the subject of this notification, the issued capital of the entity will
comprise:
3.1 Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)
	Total number of
ASX +security code and description	+securities on issue
ARX : ORDINARY FULLY PAID	342,889,208
3.2 Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)
	Total number of
ASX +security code and description	+securities on issue
ARXAD : OPTION EXPIRING 30-SEP-2025 EX $1.34	1,683,200
ARXAZ : OPTION EXPIRING 13-NOV-2027 EX NIL	1,217,610
ARXAX : OPTION EXPIRING 08-AUG-2026 EX $1.165	2,925,000
ARXAA : OPTION EXPIRING 23-JUL-2025 EX 75C	5,372,150
ARXAB : OPTION EXPIRING 01-OCT-2028 EX 10C	1,896,450
ARXAC : OPTION EXPIRING 30-NOV-2029 EX 11C	945,000
ARXAY : OPTION EXPIRING 13-NOV-2027 EX $1.165	649,695
ARXAJ : OPTION EXPIRING 30-NOV-2027 EX $1.07	20,452
ARXAE : OPTION EXPIRING 31-MAR-2026 EX $1.15	208,333
ARXAW : OPTION EXPIRING 28-JUN-2026 EX $1.06	2,295,000
ARXAF : OPTION EXPIRING 13-NOV-2027 EX $0.87	2,093,580

Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.

Notification of cessation of +securities

4 / 4